BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30733644)

  • 1. Expression signatures and roles of microRNAs in inflammatory breast cancer.
    Qi Y; Wang X; Kong X; Zhai J; Fang Y; Guan X; Wang J
    Cancer Cell Int; 2019; 19():23. PubMed ID: 30733644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas.
    Kong X; Gong S; Su L; Li C; Kong Y
    J Cell Mol Med; 2018 Jan; 22(1):123-130. PubMed ID: 28799211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA involvement in the pathogenesis and management of breast cancer.
    Khoshnaw SM; Green AR; Powe DG; Ellis IO
    J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNome of inflammatory breast cancer.
    Maltseva DV; Galatenko VV; Samatov TR; Zhikrivetskaya SO; Khaustova NA; Nechaev IN; Shkurnikov MU; Lebedev AE; Mityakina IA; Kaprin AD; Schumacher U; Tonevitsky AG
    BMC Res Notes; 2014 Dec; 7():871. PubMed ID: 25471792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment.
    Inamura K; Ishikawa Y
    J Clin Med; 2016 Mar; 5(3):. PubMed ID: 27005669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
    Asiaf A; Ahmad ST; Arjumand W; Zargar MA
    Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in colorectal cancer: small molecules with big functions.
    Xuan Y; Yang H; Zhao L; Lau WB; Lau B; Ren N; Hu Y; Yi T; Zhao X; Zhou S; Wei Y
    Cancer Lett; 2015 May; 360(2):89-105. PubMed ID: 25524553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer.
    Ding L; Gu H; Xiong X; Ao H; Cao J; Lin W; Yu M; Lin J; Cui Q
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.
    Ogony J; Choi HJ; Lui A; Cristofanilli M; Lewis-Wambi J
    Breast Cancer Res; 2016 Feb; 18(1):25. PubMed ID: 26897526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Cell-free miRNA Expression and its Association with Clinicopathologic Features in Inflammatory and Non- Inflammatory Breast Cancer.
    Hamdi K; Blancato J; Goerlitz D; Islam M; Neili B; Abidi A; Gat A; Ayed FB; Chivi S; Loffredo C; Jillson I; Elgaaied AB; Marrakchi R
    Asian Pac J Cancer Prev; 2016; 17(4):1801-10. PubMed ID: 27221856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells.
    Prabhu KS; Raza A; Karedath T; Raza SS; Fathima H; Ahmed EI; Kuttikrishnan S; Therachiyil L; Kulinski M; Dermime S; Junejo K; Steinhoff M; Uddin S
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32033146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Mir-148a in Cancer.
    Li Y; Deng X; Zeng X; Peng X
    J Cancer; 2016; 7(10):1233-41. PubMed ID: 27390598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs: non coding pleiotropic factors in development, cancer prevention and treatment.
    Fazi F; Blandino G
    Microrna; 2013; 2(2):81. PubMed ID: 25070777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in breast cancer pathogenesis.
    Götte M
    Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
    Hanieh H
    Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review on Theragnostic Applications of Micrornas and Long Non- Coding RNAs in Colorectal Cancer.
    Jothimani G; Sriramulu S; Chabria Y; Sun XF; Banerjee A; Pathak S
    Curr Top Med Chem; 2018; 18(30):2614-2629. PubMed ID: 30582478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA and colorectal cancer.
    Corté H; Manceau G; Blons H; Laurent-Puig P
    Dig Liver Dis; 2012 Mar; 44(3):195-200. PubMed ID: 22105087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression and its implications for diagnosis and therapy of gallbladder cancer.
    Li Z; Yu X; Shen J; Law PT; Chan MT; Wu WK
    Oncotarget; 2015 Jun; 6(16):13914-21. PubMed ID: 26040010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.